Letrozole - Bio-X ™

CAS: 112809-51-5

Ref. 3D-BL164620

Informação sobre produto

• Nome: Letrozole - Bio-X ™
• Sinónimos: 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile, 4,4'-(1h-1,2,4-Triazol-1-Ylmethylene) Bis-Benzonitrile, 4,4'-(1h-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile, 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, 4-[1-(4-Cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile, Benzonitrile, 4,4′-(1H-1,2,4-triazol-1-ylmethylene)bis-, Cgs 20267, Femara, Lelrozol, Lerozole, Letocor, Letoripe, Letrazole, Letrof L Lil, Letroz, Letrozol

Descrição

Letrozole is an aromatase inhibitor drug that is used in the treatment of breast cancer in postmenopausal women. It is a non-steroidal type II inhibitor that blocks the active site and thus blocking the electron transfer chain of CYP19A1. As a result of this, the conversion of androgen to estrogen is inhibited.

Letrozole is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 285.3 g/mol
• Fórmula: C₁₇H₁₁N₅
• Pureza: Min. 95%
• Cor/forma: Powder
• InChI: InChI=1S/H3N/h1H3
• Chave InChI: InChIKey=QGZKDVFQNNGYKY-UHFFFAOYSA-N
• SMILES: N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1